Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1982 1
1983 1
1984 1
1985 1
1986 1
1987 2
1988 3
1989 3
1990 4
1991 3
1992 11
1993 5
1994 5
1995 13
1996 10
1997 13
1998 8
1999 8
2000 18
2001 15
2002 12
2003 19
2004 12
2005 7
2006 11
2007 12
2008 12
2009 7
2010 10
2011 6
2012 5
2013 9
2014 8
2015 14
2016 9
2017 12
2018 5
2019 5
2020 13
2021 6
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 12518191

299 results

Results by year

Filters applied: . Clear all
Page 1
Bacillus Calmette-Guérin with or without interferon α-2b and megadose versus recommended daily allowance vitamins during induction and maintenance intravesical treatment of nonmuscle invasive bladder cancer.
Nepple KG, Lightfoot AJ, Rosevear HM, O'Donnell MA, Lamm DL; Bladder Cancer Genitourinary Oncology Study Group. Nepple KG, et al. J Urol. 2010 Nov;184(5):1915-9. doi: 10.1016/j.juro.2010.06.147. Epub 2010 Sep 17. J Urol. 2010. PMID: 20846688 Clinical Trial.
Prospective phase II trial of alternating intravesical Bacillus Calmette-Guérin (BCG) and interferon alpha IIB in the treatment and prevention of superficial transitional cell carcinoma of the urinary bladder: preliminary results.
Bazarbashi S, Raja MA, El Sayed A, Ezzat A, Ibrahim E, Kattan S, Kardar A, Peracha A, Lindstedt E, Hanash K. Bazarbashi S, et al. J Surg Oncol. 2000 Jul;74(3):181-4. doi: 10.1002/1096-9098(200007)74:3<181::aid-jso3>3.0.co;2-f. J Surg Oncol. 2000. PMID: 10951412 Clinical Trial.
Long-term outcome of patients with frequently recurrent non-muscle-invasive bladder carcinoma treated with one perioperative plus four weekly instillations of mitomycin C followed by monthly bacillus Calmette-Guérin (BCG) or alternating BCG and interferon-α2b instillations: prospective randomised FinnBladder-4 study.
Järvinen R, Marttila T, Kaasinen E, Rintala E, Aaltomaa S, Kallio J, Liukkonen T, Puolakka VM, Seppänen M, Tuhkanen K, Vaarala M, Viitanen J, Boström PJ; FinnBladder Group. Järvinen R, et al. Eur Urol. 2015 Oct;68(4):611-7. doi: 10.1016/j.eururo.2015.02.022. Epub 2015 Mar 5. Eur Urol. 2015. PMID: 25748117 Clinical Trial.
Intravesical Bacillus Calmette-Guérin Versus Combination of Epirubicin and Interferon-α2a in Reducing Recurrence of Non-Muscle-invasive Bladder Carcinoma: FinnBladder-6 Study.
Marttila T, Järvinen R, Liukkonen T, Rintala E, Boström P, Seppänen M, Tammela T, Hellström P, Aaltomaa S, Leskinen M, Raitanen M, Kaasinen E; FinnBladder Group. Marttila T, et al. Eur Urol. 2016 Aug;70(2):341-7. doi: 10.1016/j.eururo.2016.03.034. Epub 2016 Apr 13. Eur Urol. 2016. PMID: 27085624 Clinical Trial.
299 results